Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Liminatus Pharma, Inc. issued 4,000,000 shares of common stock to Clear Street LLC for surrender and cancellation of 805,377 warrants.
- Security
- common stock
- Shares
- 4,000,000 shares
- Purchaser
- Clear Street LLC
- Consideration
- surrender and cancellation of 805,377 warrants
Exact text from the filing
On February 6, 2026, Liminatus Pharma, Inc. (the “Company”) entered into a settlement and release agreement (the “Settlement Agreement”) with Clear Street LLC (the “Holder”), pursuant to which the Company agreed to issue 4,000,000 shares (the “Shares”) of its common stock, par value $0.0001 per share (“Common Stock”), to the Holder in exchange for the surrender and cancellation of 805,377 warrants (the “Warrants”) to purchase shares of Common Stock held by the Holder.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Liminatus Pharma, Inc. entered into Settlement Agreement with Clear Street LLC (effective 2026-02-06).
- Action
- entry
- Agreement
- settlement
- Counterparty
- Clear Street LLC
- Effective
- 2026-02-06
Exact text from the filing
On February 6, 2026, Liminatus Pharma, Inc. (the “Company”) entered into a settlement and release agreement (the “Settlement Agreement”) with Clear Street LLC (the “Holder”), pursuant to which the Company agreed to issue 4,000,000 shares (the “Shares”) of its common stock, par value $0.0001 per share (“Common Stock”), to the Holder in exchange for the surrender and cancellation of 805,377 warrants (the “Warrants”) to purchase shares of Common Stock held by the Holder.
View on SEC.gov